ICMR Director General Balram Bhargava said administering both doses is absolutely essential and there should be no breakage in that.
“We need to remember one thing very clearly that booster dose is not the central theme at the moment in the scientific discussion as well as in the public health domain. Getting the two doses remains the major priority,” Bhargava said.
Kidney patients worldwide are demanding an end to outdated dialysis care, characterized by staggeringly high mortality rates, and greater access to new products and solutions aimed at detecting, preventing, and treating kidney diseases earlier and in ways that improve quality of life and decrease dependency and disease-related unemployment. They are also organizing and coordinating their policy and grassroots efforts in a sophisticated effort to advance more common sense regulatory and payment reforms that prioritize patient needs and fully support the timely entry of new, safe products into global consumer markets.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.